Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSN222 in advanced solid tumors or lymphoma (phase I/II, intratumoral)
CTR20231027Phase 2Active
- Sponsor
- Taily Bio
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TSN222 in Nonhematologic neoplasms, lymphoma, sponsored by Taily Bio. Started Jul 2023; status: active.
02
Drugs
TSN222
03
Conditions
Nonhematologic neoplasmslymphoma
Beyond the preview
Go deeper on CTR20231027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231027.